Сlinical and laboratory features of Reye’s syndrome in children: a clinical case

Main Article Content

O.K. Koloskova
R.V. Tkachuk
T.M. Bilous
L.V. Kolyubakina
N.K. Bogutska


Reye’s syndrome is a very rare disease that occurs in the pediatric population with a frequency of approximately 6 cases per 100,000 children, but the mortality due to this nosology is quite high and depends on its severity and prognostic factors. This pathology should be a warning for practitioners in terms of diagnosis and timely precautions for possible progression of the disease, taking into account the high mortality rate, the rapid progression of neurological symptoms, and lack of clear predictors of Reye’s syndrome. The article presents modern views on the etiology, pathogenesis, clinical course, laboratory and morphological diagnosis of Reye’s syndrome. Recommended by the Center for Disease Control and Prevention in Atlanta criteria for the diagnosis of Reye’s syndrome are given in the article. The article describes the differential diagnosis between classical (aspirin-associated, idiopathic) and atypical Reye’s syndrome (Reye’s-like syndrome), as well as focuses on a set of diagnostic and therapeutic measures. A clinical case of the classic Reye’s syndrome in pediatric practice is presented, which occurred in the Regional Municipal Non-Profit Enterprise “Chernivtsi Regional Children’s Clinical Hospital”. The presented clinical case, unfortunately, was fatal and the body was subjected to an autopsy, the results of which, as well as morphological changes in the section material after specific staining with Sudan III, are also described in the article. The review of the case ends with a summary and conclusions, authors emphasize the need to draw the attention of practitioners to the possibility of developing rare Reye’s syndrome in children after the use of acetylsalicylic-containing drugs; for the verification of nosology, a doctor should take into account specific changes in clinical and paraclinical parameters, and due to the absence of a minimum permitted dose of acetylsalicylic acid it should be prohibited for use in pediatric practice as an antipyretic drug.

Article Details

How to Cite
Koloskova, O., R. Tkachuk, T. Bilous, L. Kolyubakina, and N. Bogutska. “Сlinical and Laboratory Features of Reye’s Syndrome in Children: A Clinical Case”. CHILD`S HEALTH, vol. 16, no. 4, Sept. 2021, pp. 309-16, doi:10.22141/2224-0551.16.4.2021.237278.
Case Report


Reye RD, Morgan G, Baral J. Encephalopathy and fatty degeneration of the viscera. A disease entity in childhood. Lancet. 1963 Oct 12;2(7311):749-752. doi:10.1016/s0140-6736(63)90554-3.

Badalian LO, Berestov AI, Blokhin BM, et al. Reye’s syndrome in children. Zhurnal Nevrologii i Psikhiatrii imeni SS Korsakova. 1990;90(8):109-113. (in Russian).

Tereshchenko SY, Smolnikova MV, Gorbacheva NN, Shubina MV. Inherited deficiency of carnitine palmitoyltransferase 1A, as one of the variants of mitochondrial fatty-acid oxidation disorders with impaired fatty acids beta oxidation: diagnosis and therapeutic tactics. International Journal of Applied and Fundamental Research. Medical Sciences. 2014;(11):847-854. (in Russian).

Zborovskii AB, Tiurenkov IN, Belousov IuB. Adverse drug side effects. Moscow: MIA; 2008. 656 p. (in Russian).

Weiner DL, Bechtel KA, Bachur RG, Wilkes G, Windle ML, Young GM. Reye syndrome. Available from: https://emedicine.medscape.com/article/803683-overview. Accessed: April 2, 2018.

Ikeda K, Sonoda K. A case of Reye's-like syndrome due to suspected Bordetella pertussis infection in an adult. Kansenshogaku Zasshi. 2009 Nov;83(6):658-660. doi:10.11150/kansenshogakuzasshi.83.658. (in Japanese).

Jones DB, Mullick FG, Hoofnagle JH, Baranski B. Reye's syndrome-like illness in a patient receiving amiodarone. Am J Gastroenterol. 1988 Sep;83(9):967-969.

Schmidt D. Anticonvulsants. In: Dukes MNG, editor. Meyler’s side effects of drugs. 12th ed. Amsterdam: Elsevier;1992. 122-143 pp.

Koloskova OK, Bezrukov LO, Ivanova LA, et al. Nevidkladni stany u pediatrii' [Emergencies in pediatrics]. Chernivtsi: Misto; 2017. 97-81 pp. (in Ukrainian).

Berezhnyj VV. Pediatrija: nacional'nyj pidruchnyk. Tom 2 [Pediatrics: a national textbook. Vol 2]. Kyiv; 2013. 932-934 pp. (in Ukrainian).

Tsyganenko AIa, Zhukov VI, Leonov VV, Miasoedov VV, Zavgorodnii IV. Klinicheskaia biokhimiia [Clinical Biochemistry]. Kharkiv: Fakt; 2005. 318-319 pp. (in Russian).

Gubs'kyj JuI. Biologichna himija [Biological Chemistry]. Kyiv-Ternopil; Ukrmedknyga; 2000. 86-269 pp. (in Ukrainian).

Ministry of Нealth of Ukraine. Order on December 11, 2003 № 572. On state registration of medical products. (in Ukrainian).

Centers for Disease Control and Prevention (CDC); National Notifiable Diseases Surveillance System (NNDSS). Reye Syndrome 1990 Case Definition. Available from: https://ndc.services.cdc.gov/case-definitions/reye-syndrome-1990/. Accessed: April 16, 2021.

Davis LE, Kornfeld M. Influenza A virus and Reye's syndrome in adults. J Neurol Neurosurg Psychiatry. 1980 Jun;43(6):516-521. doi:10.1136/jnnp.43.6.516.

National Reye’s Syndrome Foundation UK; Royal College of Paediatrics and Child Health (RCPCH). Reye’s syndrome. Available from: www.reyessyndrome.co.uk.

Glasgow JF, Middleton B, Moore R, Gray A, Hill J. The mechanism of inhibition of beta-oxidation by aspirin metabolites in skin fibroblasts from Reye's syndrome patients and controls. Biochim Biophys Acta. 1999 May 31;1454(1):115-125. doi:10.1016/s0925-4439(99)00025-3.

Vengrovskii AI, Batunina NO, Saratikov FS. Reye's syndrome - a severe complication of salicylate therapy. Eksperimentalnaya i Klinicheskaya Farmakologiya. 2000;63(2):76-80. (in Russian).

Most read articles by the same author(s)